Literature DB >> 12876399

Expression and function of tumour necrosis factor-alpha-converting enzyme in the central nervous system.

Maria A Moro1, Olivia Hurtado, Antonio Cárdenas, Cristina Romera, Jose L M Madrigal, Paz Fernández-Tomé, Juan C Leza, Pedro Lorenzo, Ignacio Lizasoain.   

Abstract

Tumour necrosis factor-alpha (TNF-alpha)-converting enzyme (TACE/ADAM17) is a membrane protein belonging to the ADAM (a disintegrin and a metalloprotease) family able to cleave various membrane proteins, including the transmembrane form of TNF-alpha at its physiological processing site. Being an ADAM, TACE may mediate not only proteolysis but also adhesive interactions; however, the role of the disintegrin domain of TACE has not been studied. In the central nervous system (CNS), little is known about the physiological role of TACE, but some important pathophysiological functions have been reported recently, with both neurotoxic and neuroprotective repercussions. This article discusses and reviews the main contributions to this field of investigation addressing the expression and function of TACE in the CNS. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12876399     DOI: 10.1159/000071814

Source DB:  PubMed          Journal:  Neurosignals        ISSN: 1424-862X


  7 in total

1.  Cytokine and chemokine responses in serum and brain after single and repeated injections of lipopolysaccharide: multiplex quantification with path analysis.

Authors:  Michelle A Erickson; William A Banks
Journal:  Brain Behav Immun       Date:  2011-06-17       Impact factor: 7.217

Review 2.  Endocannabinoids and traumatic brain injury.

Authors:  R Mechoulam; E Shohami
Journal:  Mol Neurobiol       Date:  2007-09-18       Impact factor: 5.590

3.  Signaling pathways involved in LPS induced TNFalpha production in human adipocytes.

Authors:  Laurence Hoareau; Karima Bencharif; Régis Roche; Franck Festy; Philippe Rondeau; Ravi Murumalla; Palaniyandi Ravanan; Frank Tallet; Pierre Delarue; Maya Cesari
Journal:  J Inflamm (Lond)       Date:  2010-01-08       Impact factor: 4.981

4.  IL-6-trans-signalling increases rapid-eye-movement sleep in rats.

Authors:  Ulrike May; Thomas Schiffelholz; Paul Christian Baier; James M Krueger; Stefan Rose-John; Jürgen Scheller
Journal:  Eur J Pharmacol       Date:  2009-04-19       Impact factor: 4.432

5.  Deficiency of TNFalpha converting enzyme (TACE/ADAM17) causes a lean, hypermetabolic phenotype in mice.

Authors:  Richard W Gelling; Wenbo Yan; Salwa Al-Noori; Aaron Pardini; Gregory J Morton; Kayoko Ogimoto; Michael W Schwartz; Peter J Dempsey
Journal:  Endocrinology       Date:  2008-08-07       Impact factor: 4.736

6.  TNF-alpha converting enzyme (TACE) protein expression in different clinical subtypes of multiple sclerosis.

Authors:  Manuel Comabella; Cristina Romera; Montse Camiña; Hector Perkal; María A Moro; Juan C Leza; Ignacio Lizasoain; Mireia Castillo; Xavier Montalban
Journal:  J Neurol       Date:  2006-03-06       Impact factor: 4.849

Review 7.  Studies of selective TNF inhibitors in the treatment of brain injury from stroke and trauma: a review of the evidence to date.

Authors:  Antonino Tuttolomondo; Rosaria Pecoraro; Antonio Pinto
Journal:  Drug Des Devel Ther       Date:  2014-11-07       Impact factor: 4.162

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.